Only a slight trend of upregulation after IL‐36γ treatment was observed for CCL20, CXCL10, CXCL6, and CXCL5 (Table S1 ).
← all excerpts
IL1RAP Expression in Human Atherosclerosis: A Target of Novel Antibodies to Reduce Vascular Inflammation and Adhesion.
1
—
—